Targeting Endogenous K-RAS for Degradation through the Affinity-Directed Protein Missile System
{{output}}
K-RAS is known as the most frequently mutated oncogene. However, the development of conventional K-RAS inhibitors has been extremely challenging, with a mutation-specific inhibitor reaching clinical trials only recently. Targeted proteolysis has emerged as a n... ...
